The 2005 Stem Cells Symposium - A Joint Swedish-Californian Collaborative Venture

Venue: The Hyatt Regency San Francisco Airport Hotel

Location: Burlingame, California, United States

Event Date/Time: Apr 26, 2005 End Date/Time: Apr 27, 2005
Early Registration Date: Mar 27, 2005
Report as Spam


San Francisco, CA - This April, the world’s leading stem cells researchers from Sweden and California will join pioneers from the fields of life sciences, finance and the legal community to map out the future of stem cells research and development in California. The 2005 Stem Cells Symposium, on April 26-27th, is organized by the Consulate General of Sweden in San Francisco, the Swedish-American Chamber of Commerce in San Francisco/Silicon Valley, the Swedish Office of Science and Technology in Los Angeles and Astragen LLC and will bring together the scientific and business expertise required to build bilateral world-class research programs that foster entrepreneurship.

The Symposium will feature six keynote addresses from world-renowned researchers and leading experts in the stem cells field, and over 12 other researchers and business representatives will address cutting-edge issues in a series of panel discussions.

The Symposium will also arrange meetings of researchers, companies and potential financiers to spark international research and business ventures, both in the context of California's “Proposition 71” funding and beyond.

“Sweden has one of the most advanced Stem Cells research programs in the world today,” says Dr. Kent Persson, member of the Board of Directors at Astragen LLC and the Chair of the Symposium’s Advisory Committee. “The Symposium will attract top level stem cells researchers and bring together both Swedish and Californian businesses with Stem Cells Research for world class entrepreneurial ventures,” says Dr. Neerja Sethi, member of the Board of Directors at Astragen LLC and the Symposium’s Advisory Committee.

“This is a unique opportunity for Swedish and American stem cells researchers and entrepreneurs to exchange knowledge for continued expansive stem cells research,” says Mr. Nils Welin, Executive Director Swedish American Chamber of Commerce.

“We look forward to bringing together researchers, companies, policy makers and others from Sweden and the US in this very important area. Due to California’s Proposition 71 stem cells funding initiative, there is a great potential to form joint ventures between Swedish and US concerns. Progress in the stem cells area will most likely lead to major health benefits and economic growth in our countries,” says Helena Jonsson-Franchi, Swedish Attaché of Science and Technology, at the Swedish Office of Science and Technology in Los Angeles.

This will be a “continuing symposium,” with follow-up meetings in future years to map progress and continue to steer the course for future international cooperation in this important area of scientific, business and governmental cooperation.


1333 Bayshore Highway
United States

Additional Information

Keynote Speakers and Leading Panelists, Swedish-California Stem Cells Symposium This is a preliminary list of speakers and leading panelists. The following researchers have accepted invitations to speak at the Symposium. Other leading researchers from Sweden and the United States have been invited as well. KEYNOTE SPEAKERS AND PANELISTS FROM SWEDEN Keynote Speakers • Anders Björklund, MD, PhD, Prof., Wallenberg Neuroscience Center, Division of Neurobiology, Lund University. • Sten Eirik W. Jacobsen, MD, PhD, Prof. of Stem Cell Biology, Head Hematopoietic Stem Cell Laboratory, Director Lund Stem Cell Center, Lund University • Henrik Semb, PhD, Prof. of Functional Genetics, Lund University. Co-founder of Cellartis AB. • Lars Ährlund-Richter, PhD, Prof., Director, Unit for Molecular Embryology, Clinical Research Center, Karolinska Institutet. Panelists • Ernest Arenas, MD, PhD, Prof., Laboratory of Molecular Neurobiology, Karolinska Institutet. Founder and Board member of NeuroTherapeutics AB. • Leif Carlsson, PhD, Umeå University Center for Molecular Medicine. • Peter Eriksson, PhD, Prof., Head of Research, The Arvid Carlsson Institute for Neuroscience, Sahlgrenska Academy, Gothenburg University. Co-founder of Cellartis AB. • Lars Hamberger, PhD, Prof., Sahlgrenska University Hospital, Gothenburg University. Co-founder of Cellartis AB. • Johan Häggblad, PhD, Head of Business Development, Neuronova, Sweden. Formerly Director of Lead Discovery at NeuroNova (2001-2003). Prior to joining NeuroNova, Dr Häggblad held a number of management positions at KaroBio AB (1989-1997) and at Pharmacia Corporation (1997-2001) in the areas of discovery research, licensing operations and project portfolio management. Dr Häggblad holds a PhD from the University of Stockholm. • Anders Vedin, MD, PhD, Chairman and Co-founder of Cellartis AB, Gothenburg, Sweden. Founder Vedicon Consultancy. KEYNOTE SPEAKERS AND PANELISTS FROM THE UNITED STATES Keynote Speakers • Arnold R. Kriegstein, PhD, Prof., Director, Program in Developmental and Stem Cell Biology, UCSF School of Medicine. • Jane Lebkowski, PhD, Senior Vice President of Tissue Regenerative Medicine, Geron Corporation. Dr. Lebkowski joined Geron Corporation as the Senior Director of Cell and Gene Therapies, and is currently Senior Vice President of Regenerative Medicine. Dr. Lebkowski heads the human embryonic stem cell program at Geron, and coordinates both preclinical research and product development activities. Panelists • Rik Derynck, PhD, Prof., Department of Cell & Tissue Biology, University of California, San Francisco. • Susan Fisher, PhD, Prof., Department of Cell and Tissue Biology, University of California San Francisco. • Michael German, MD, Prof., UCSF Diabetes Center, University of California, San Francisco. • Gregg Kyle, Licensing Associate, Biotech Licensing, Stanford University. • Renee A. Reijo Pera, PhD, Co-director, Program in Human Stem Cell Biology, UCSF. • David Warburton, D.Sc., MD, Prof., USC Keck School of Medicine and School of Dentistry, Leader, Developmental Biology Program, Children’s Hospital, Los Angeles, Saban Research Institute. BUSINESSES REPRESENTED AT THE SYMPOSIUM Names through February 1 • Burrill & Company • Cellartis AB • Geron Corporation • NeuroNova AB • Neurotherapeutics AB • Pillsbury Winthrop LLP • Vedicon Consultancy Price: Early registration discount ends March 27th. More information and registration on